ViewPoint Therapeutics, Inc. — Form D
ViewPoint Therapeutics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2016-05-02. The offering totals $4.0M, of which $4.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-05-02
- Form: D
- Accession: 0001673242-16-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $4.0M
- Investors: 17
- Date of first sale: 2016-04-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-262446
Issuer
- Name: ViewPoint Therapeutics, Inc.
- CIK: 0001673242
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 953 INDIANA STREET, SAN FRANCISCO, CA, 94107
- Phone: 628-213-5149
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Mark T Blumenkranz, M.D. | Director | San Francisco, CA |
| Douglas T Crawford | Director | San Francisco, CA |
| Jason E Gestwicki | Director | San Francisco, CA |
| Ed Hurwitz | Executive Officer | San Diego, CA |
| Ed Hurwitz | Director | San Diego, CA |
| Leah Makley | Director | San Francisco, CA |
| Leah Makley | Executive Officer | San Francisco, CA |
| Peter T Moldt | Director | San Francisco, CA |
| Emmett T Cunningham, Jr. | Director | San Francisco, CA |
| Heath T Lukatch | Director | San Francisco, CA |
Other filings by this issuer (1)
More